openPR Logo
Press release

Anxiety and Panic Disorders Drugs Market – Global Need Assumptions 2025 | AstraZeneca, Eli Lilly

02-07-2019 12:46 PM CET | Health & Medicine

Press release from: TMR Research

/ PR Agency: TMR Research
Anxiety and Panic Disorders Drugs Market – Global Need

Global Anxiety and Panic Disorders Drugs Market: Snapshot

One of the key growth promoting factors for this market is daily stress of life and that keeps on increasing. This is an era where demands of modern lifestyle and modernization come at a cost and with a set of various limitations. The modern culture comes with the fear of being unemployed, heavier load of work, personal and professional issues, night shifts, tight deadline and so on. These day to day challenges that are faced by an individual over a long period of time along with unhealthy lifestyles result in many of the mental disorders, one such being anxiety and panic disorders.

Various advancements in the field of science and technology such as new DNA-editing technologies and genetic engineering have helped researchers in obtaining a better and deep insight of the genes that are linked with the constant progress of anxiety disorders and it assists the researchers to come up with much improved of target therapies so as to treat them more effectively. The gene NTRK3 is held accountable for causing such a panic disorder as the deregulation of this particular gene results in the malfunctioning of the memory system that is related to fear. As such, an extensive research on this particular gene under the field of neurogenetics allows the researchers to develop and bring forth various treatment therapies that directly treat that very area of the brain that is affected and generates pharmacological effects.

Request Sample Copy of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=2507

One of the key trends that is prevailing in the world market for anxiety and panic disorders drugs

is the synergistic effects of medication that is aided with neuromodulation devices and the same trend is foreseen to continue throughout the period of forecast that extends from the year 2017 to 2025. The neuromodulation refers to a novel psychiatric treatment and when one undergoes that treatment and also when it is taken with the traditional therapeutic regimen, it provides a complete and all inclusive treatment for anxiety and panic disorders. This method of treatment is further expected to positively impact the acceptance of these drugs in the market and thereby stimulate the growth of the global market for anxiety and panic disorders drugs.

Global Anxiety and Panic Disorders Drugs Market: Overview

Anxiety and panic disorders affect millions of people across the globe. Collectively, afflicted people seeking to stem the malaise are known to spend billions of dollars on it. While anxiety is a result of individuals unable to cope up with stress or undue worry sometimes without any perceptible external trigger, a panic disorder is more serious and usually strikes without reason or warning.

Anxiety disorders include social anxiety, generalized anxiety disorder, and panic disorders. Symptoms of panic disorders typically are sudden and extreme bouts of fear and nervousness that often manifest through physical symptoms such as a pounding heart and profuse sweating. Both anxiety attacks and panic attacks can be treated using medication and psychotherapy.

Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=2507

Global Anxiety and Panic Disorders Drugs Market: Key Trends

The global anxiety and panic disorders drugs market is expected to rise steadily on account of more individuals recognizing the condition and seeking treatments and due to progress in neurogenetics. The emergence and gigantic progress of genetic engineering and the relatively new DNA-editing technologies that have provided better insights into genes related to progression of anxiety disorders has subsequently helped in developing target therapies for cure.

A key trend noticed in the anxiety and panic disorders drugs market is the combination of medication and neuromodulation devices. Neuromodulation is a unique psychiatric treatment, which coupled with traditional therapeutic regimen, brings about a holistic treatment of anxiety and panic disorders. This is expected to lead to swifter uptake of the drugs thereby driving growth in the market in the near future.

Global Anxiety and Panic Disorders Drugs Market: Market Potential

With more and more people reporting anxiety and panic disorders, scientists, researchers, and organizations are making every effort to come up with innovative methods to treat the conditions. Researchers from Columbia University and the University of Wisconsin-Milwaukee, for example, are redesigning a drug compound first created by UWM's James Cook to calm anxiety without dangerous side effects. They have already overcome crucial challenges in the process.

Government efforts are also creating opportunities for growth in the market. The Ontario government in the nation of Canada, for instance, announced that it would make prescription medications free for all children and youth under 24 years of age. Medications that will be covered include drugs to treat depression, asthma inhalers, anxiety and attention deficit hyperactivity disorder, antibiotics and oral contraceptives. Once implemented, the rule would likely create opportunities in the anxiety and panic disorders drugs market.

Read Comprehensive Overview of Report @ www.tmrresearch.com/anxiety-panic-disorders-drugs-market

Currently, the two types of drugs available in the market can be broadly segmented into antidepressant drugs and anxiolytic drugs. Of the two, the antidepressant drugs could gross maximum revenue in the next couple of years on the back of the launch of newer selective serotonin reuptake inhibitor (SSRIs) with safer side effects.

Global Anxiety and Panic Disorders Drugs Market: Regional Outlook

Geographically, the key segments of the global anxiety and panic disorders drugs market are Asia Pacific, Europe, North America, and the Rest of the World. North America, among them, is primed to be a key market due to the alarming increase of anxiety disorders and the subsequent visits to psychiatrists for cure.

Global Anxiety and Panic Disorders Drugs Market: Competitive Analysis

In order to assess the competition prevailing in the global market for anxiety and panic disorders drugs, the report profiles prominent players such as AstraZeneca, Eli Lilly, GlaxoSmithKline, and Pfizer.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anxiety and Panic Disorders Drugs Market – Global Need Assumptions 2025 | AstraZeneca, Eli Lilly here

News-ID: 1568967 • Views: 176

More Releases from TMR Research

Dietary Supplements Market Analysis by Growth, Size (Value and Volume), Trends 2 …
Global Dietary Supplements Market: Overview Changing lifestyles and swift urbanization are the major drivers for the use of dietary supplements. The demand for such products is projected to increase due to growing awareness on importance of health and weight management among worldwide millennial population. This opens the doors for growth of the global dietary supplements market during the upcoming period. Based on forms, the global dietary supplements market is classified into soft
Resistant Starch Market Future Innovation Strategies 2029
Global Resistant Starch Market – Overview Resistant starch contains a low glycemic index and carbohydrates. This makes it an important element in a diet that protects people from stroke, coronary heart disease, obesity, hypertension, and most importantly Type-2 diabetes. Since Resistant starch helps in increasing insulin sensitivity in a human body, it helps in fighting diabetes. Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6588 Global Resistant Starch Market – Competitive Landscape The competitive of the
Botanical Ingredients Market Qualitative Insights On Application 2029
Global Botanical Ingredients Market: Overview The demand for organic ingredients by food and beverages industry has skyrocketed in past few years. This demand is backed by the health conscious enthusiasts that are very peculiar about their diet and food consumptions. Owing to these demands, the global botanical ingredients market shall witness a substantial growth during the tenure or 2019 to 2029. Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6589 A report by TMR
Citronella Oil Market to Expand with Significant CAGR During 2029
Citronella oil market: Overview Demand for essential oil types has experienced a stellar growth rate. One of them is the citronella oil market. Growing demand of the citronella oil is crystal clear. This may mean a rise in the graph regarding the growth of the citronella oil market. Citronella oil is a significant oil type that’s extracted from a selected plant species of the Cymbopogon family. This plant, commonly known as

All 5 Releases


More Releases for Anxiety

Free Hypnosis Download for Coronavirus Anxiety
Eli Bliliuos, founder and President, of NYC Hypnosis Center has just released a free hypnosis download to help anyone who is suffering from anxiety and stress due to the Coronavirus pandemic. The free Hypnosis MP3 for Coronavirus Anxiety (24 hours only), called "Clear Your Mind", can provide a break from the repetitive thoughts related to the outbreak. It can help program the mind to recognize that this Coronavirus pandemic will
Generalized Anxiety Disorder (GAD) Market 2023 By Top Players
Generalized anxiety disorder is characterized by excessive anxiety and worry about everyday life events with no apparent reason. The patient cannot stop worrying about health, family, money, or work and eventually anxiety dominates the person thinking, that interfere with daily functioning of person. Symptoms of generalized anxiety disorder includes an unrealistic view of problems, muscle tension, headache, sweating, and tiredness. Additionally, rarely GAD occurs alone as it often
General Anxiety Disorder Market Worldwide Growth by 2020
General Anxiety Disorder Market by Therapeutics (Antidepressant, Benzodiazepines and Others): U.S. Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast 2014 – 2020. U.S. general anxiety disorder market expected to reach USD 3,775 million by end of 2020, growing at a CAGR of 2.4% during 2015 and 2020. The report covers forecast and analysis for the general anxiety disorder market U.S. region. The study provides historic data of 2014 along
General Anxiety Disorder Market Revenue Share, By Therapeutics, 2015 - 2021
Zion Market Research has published a new report titled “General Anxiety Disorder Market by Therapeutics (Antidepressant, Benzodiazepines and Others): U.S. Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020.” According to the report, The U.S. demand for general anxiety disorder market was valued at USD 3,251 million in 2014, and is expected to generate revenue of USD 3,775 million by end of 2020, growing at a CAGR of 2.4% between
No Pain, No Anxiety, Exceptional Care
NYC Smile Design finds the perfect balance to patient care, by using the latest advances in dental technology to treat pain and anxiety, and extending its extraordinary cosmetic and technical skills to treating the whole patient. Hailed by Newsweek as “two of Manhattan's most respected and accomplished cosmetic dentists,” Drs. Ramin Tabib and Elisa Mello have perfected a new treatment strategy that guarantees their patients pain-free and relaxed visits to the
IT Manager Uses "Sleep Tracks" to Combat Insomnia and Anxiety
SAN FRANCISCO, California (December 7, 2010) As a new research indicates that software engineeers are working too hard and suffer from job-related stress, insomnia and anxiety, Karl Ramm says he found a viable solution. The California-based technology manager reports listening to specialized audio sessions to alleviate his work-induced stress and anxiety -- and get the sleep he desperately needs. "I was having a lot of anxiety before sleeping and could not